PMCPA Case
| Case number | AUTH/3476/2/21 |
| Parties | Anonymous, contactable complainant v Leo Pharma |
| Issue | Alleged Code breaches arising from a Leo employee’s LinkedIn profile (qualification claim; references to Innohep and Picato; “switch” wording; “safe” wording; alleged promotion to public/HCPs; alleged lack of prescribing information/certification) |
| Medicines mentioned | Innohep; Picato (ingenol mebutate) |
| Applicable Code year | 2019 |
| Complaint received | 9 February 2021 |
| Case completed | 18 November 2021 |
| Panel outcome | Initially ruled some breaches (later appealed) |
| Appeal outcome | Appeal successful; all breaches overturned; no breach of the Code |
| Additional sanctions | None |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.